• #1120530
  • 540
  • Sanofi Pasteur #49281071910

Flublok® Quadrivalent 2019 - 2020 Flu Vaccine 180 mcg / 0.5 mL Indicated For People 18 Years and Above Prefilled Syringe 0.5 mL

FLUBLOK 2019 QUAD, SYR 0.5ML (10DOSE/BX)

Features
  • Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine
  • Flublok Quadrivalent is approved for use in persons 18 years of age and older
  • Flublok contains no egg proteins, antibiotics, or preservatives
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1120530
Manufacturer #49281071910
BrandFlublok® Quadrivalent 2019 - 2020
ManufacturerSanofi Pasteur
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number49281071910
Storage RequirementsRequires Refrigeration
Strength180 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 18 Years and Above
Volume0.5 mL
Features
  • Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine
  • Flublok Quadrivalent is approved for use in persons 18 years of age and older
  • Flublok contains no egg proteins, antibiotics, or preservatives
  • Flublok Quadrivalent is standardized according to United States Public Health Service (USPHS) requirements. For the 2019-2020 influenza season it is formulated to contain 180 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 4 influenza virus strains: A/Brisbane/02/2018 (H1N1), A/Kansas/14/2017 (H3N2), B/Maryland/15/2016 (a B/Colorado/6/2017-like virus) and B/Phuket/3073/2013.
More Information